Scientific Committee

Claus Y. Andersen, Denmark
Claus Yding Andersen is professor in human reproductive physiology at the Faculty of Health Sciences, University of Copenhagen, Denmark and has since 2009 been heading Laboratory of Reproductive Biology at the University Hospital of Copenhagen, Denmark. Claus Yding Andersen qualified first as MSc from the Danish Technical University (1979) and obtained his DMSc from University of Copenhagen in 1997.
He was member of the team which introduced IVF to Denmark in the mid 1980´ties and he has worked at the Laboratory of Reproductive Biology at University Hospital of Copenhagen since then. During the last ten years he has been heading a national program of cryopreservation of human ovarian tissue. His major research contributions have been in ovarian endocrinology, cryopreservation of gonadal tissue and human embryonic stem cells. He serves on the editorial board of a number of scientific journals and research committees. He has published more 200 peer-reviewed scientific papers and has given a large number of international presentations.
Marie-Madeleine Dolmans, Belgium
Marie-Madeleine Dolmans earned her medical degree from the Université Catholique de Louvain in Brussels in 2000, and her PhD degree on "Cryopreservation and transplantation of human ovarian tissue” in 2006. She completed her internship in Gynecology and Obstetrics in 2007 and since then has divided her time equally between clinical and research activities. Her research work focuses primarily on human ovarian follicle isolation and xenotransplantation, and the risk of reimplanting malignant disease.
Jacques Donnez, Belgium
Jacques Donnez was born in Tournai (Belgium) in 1947. He studied at the Catholic University of Louvain. He became Full Professor and Head of the Dept Gynaecology and Andrology in 1986 and is emeritus since October 2012. He also founded the Infertility Research Unit of the Catholic University of Louvain in 1986. He has focused his research activities on three main topics: tubal infertility, endometriosis and finally, ovarian cryopreservation and transplantation. He published over 600 original articles in peer-review journals. Prof. Donnez was the first President of the recently created International Society for Fertility Preservation (until end of 2010) and has been elected in 2009 at the Royal Belgian Academy of Medicine.
Outi Hovatta, Sweden
At present Professor in Obstetrics and Gynaecology, especially Assisted Reproduction, in the Karolinska Institutet, Stockholm, Sweden since 1998. She graduated from the University of Helsinki, Finland with MD in 1970 and PhD in 1973, specialist in Obstetrics and Gynaecology 1978. She was Senior Research Fellow and Visiting Professor, Imperial College School of Medicine, Hammersmith Hospital, London, UK , 1995-98. In 2008 a Visiting Professor in the University of Geneva, Switzerland.

Her main research topics have evolved from developmental biology of testicular function to causes and treatment of male infertility, improvement in clinical in vitro fertilisation, fertility preservation including cryopreservation of gonadal tissues, maturation of human ovarian follicles in vitro, and as a continuation of cultures of human eggs and embryos, to stem cell research during the latest 15 years. The focus of the human embryonic stem cell research has been directed to their use in regenerative medicine and her team has established more than 60 human embryonic stem cells lines. The latest ones have been established without feeder cells on chemically defined matrix and culture medium that does not contain any substances of animal origin. Her H-index is 50. She has published over 300 original articles and reviews, 50 book chapters and articles in popularising medicine.
Dror Meirow, Israel
Professor Dror Meirow is the head of the Clinical Center for Fertility Preservation and the Fertility Preservation Research Laboratory at Sheba Medical Center, Tel-Hashomer, Israel. Prof. Meirow is also a Professor at the Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Prof. Meirow received his M.D. from the Hebrew University, Jerusalem, Israel. He then specialized and practiced as a senior physician in Obstetrics and Gynecology at Hadassah University Hospital. He conducted his basic research training at the Center for Reproduction Growth and Development, University of Leeds, UK, led by Prof. Roger Gosden. Since 2001, he has headed the Clinical Center for Fertility Preservation and the Fertility Preservation Research Laboratory at Sheba Medical Center. He has supervised dozens of students and doctors in their basic and clinical research in the field of fertility preservation.

Professor Meirow's basic and clinical research is focused on the effects of chemotherapy on reproduction, and modalities for fertility preservation in cancer patients, including ovarian tissue harvesting for fertility preservation, IVF and embryo freezing, and medications that can prevent chemotherapy-induced ovarian damage. He has written more than a hundred original articles, reviews, monographs, book chapters and position papers on these subjects. Prof. Meirow reported in the New England Journal of Medicine the first case of IVF, pregnancy, and delivery of a healthy baby to result from transplantation of cryopreserved thawed ovarian tissue in a sterilized former cancer patient. Recently, a team of researchers from Prof. Meirow's laboratory published a pioneer study in Science TM Journal providing a new understanding of the mechanisms involved in chemotherapy-induced ovarian damage, and testing a novel fertility protecting agent. For their achievements the team of researchers led by Prof. Meirow received dozens of national and international grants during the last years.

Prof. Meirow was among the founders of the Fertility Preservation Special Interest Group (PFSIG) of the ASRM and is currently on the board of International Society of Fertility Preservation (ISFP) and the ESHRE Fertility Preservation task force.

Hamish Wallace, UK
I am a Consultant Paediatric Oncologist at the Royal Hospital for Sick Children, Edinburgh (since 1992) and Honorary Professor in the School of Clinical Sciences and Community Heath at the University of Edinburgh.
I have been a member of several national working parties (RCOG and BFS) representing the RCPCH as an expert in fertility preservation and assessment of young people with cancer. I am a founding member of ISFP.

I have chaired two SIGN guidelines on the late effects of the treatment of cancer. In 2002 I took over the chair of the UK children's cancer group working party on Hodgkin's Lymphoma. I am President of EuroNet, the European network for paediatric Hodgkin's lymphoma. I am Chief Investigator in the UK for the currently open and recruiting clinical trial for children and young people up to the age of 18 years with classical Hodgkin's lymphoma (EuroNet-PHL-C1).

I was Lead Clinician for the Children and Teenagers Scottish Cancer Network (CATSCAN) 2007-10.

My research focuses on the late effects of treatment on survivors of childhood cancer, fertility preservation, and clinical trials of Hodgkin's lymphoma. I have co-authored four books and published more than 140 research articles.